Efficacy and Tolerability of Reboxetine in Depressive Patients Treated in Routine Clinical Practice

ISSN： 1172-7047

Source： CNS Drugs, Vol.19, Iss.1, 2005-01, pp. : 43-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tolerability and Efficacy of Intravenous Administration of Pantoprazole in Routine Clinical Practice

By Bosseckert H.

Clinical Drug Investigation, Vol. 19, Iss. 2, 2000-02 ,pp. : 103-109

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Moxifloxacin in Patients with Respiratory Tract Infections Treated in General Practice: Results of a Post-Marketing Surveillance Study

By Chen Weiqiang Wu Changgui Li Zhikui Bai Changqing

Clinical Drug Investigation, Vol. 26, Iss. 9, 2006-01 ,pp. : 501-509

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Moxifloxacin in Patients with Sinusitis Treated in General Practice: Results of a Post-Marketing Surveillance Study

By W. Elies

Clinical Drug Investigation, Vol. 24, Iss. 8, 2004-01 ,pp. : 431-439

Adis International

Access to resources Recommend Favorite

Reboxetine effective for depression in clinical practice

Inpharma, Vol. 1, Iss. 1474, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Efficacy and tolerability of the histone deacetylase inhibitor panobinostat in clinical practice

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 210-216

John Wiley & Sons Inc

Access to resources Recommend Favorite